Evidence map›Paper›PMID 26645089›Full record

ArticlePhysiological genomics2016

Characterizing a distal muscle enhancer in the mouse Igf2 locus.

Damir Alzhanov, Peter Rotwein

Abstract read
In one paragraph

Article in Physiological genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. IGF2 deficiency causes mitochondrial defects in skeletal muscle.Clinical science (London, England : 1979) · 2021
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Damir AlzhanovDepartment of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, Oregon; and.
Peter RotweinDepartment of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, Oregon; and Department of Biomedical Sciences, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, Texas peter.rotwein@ttuhsc.edu.
Oregon Health & Science University · US

Funding

INSULINLIKE GROWTH FACTORS AND MUSCLE DIFFERENTIATIONR01DK042748 · NIDDK · WASHINGTON UNIVERSITY · PI ROTWEIN, PETER S · 1991 to 2017
$5.6M
NIDDK NIH HHS R01 DK042748NIDDK NIH HHS R01 DK-042748-25
6 · The paper itself

Abstract

Insulin-like growth factor-2 (IGF2) is highly expressed in skeletal muscle and was identified as a quantitative trait locus for muscle mass. Yet little is known about mechanisms of its regulation in muscle. Recently, a DNA segment found ∼100 kb from the Igf2 gene was identified as a possible muscle transcriptional control element. Here we have developed an in vivo reporter system to assess this putative enhancer by substituting nuclear (n) EGFP for Igf2 coding exons in a bacterial artificial chromosome containing the mouse Igf2 - H19 chromosomal locus. After stable transfection into a mesenchymal stem cell line, individual clones were converted to myoblasts and underwent progressive muscle-specific gene expression and myotube formation in differentiation medium. Transgenic mRNA and nuclear-targeted enhanced green fluorescent protein were produced coincident with endogenous Igf2 mRNA, but only in lines containing an intact distal conserved DNA element. Our results show that a 294 bp DNA fragment containing two E-boxes is a necessary and sufficient long-range enhancer for induction of Igf2 gene transcription during skeletal muscle differentiation and provides a robust experimental platform for its further functional dissection.

Indexed as

Enhancer Elements, GeneticAnimalsCell DifferentiationCell NucleusChromosomesCulture MediaExonsGene Expression RegulationGreen Fluorescent ProteinsImmunohistochemistryInsulin-Like Growth Factor IIMiceMice, TransgenicMuscle Fibers, SkeletalMusclesMuscle, SkeletalCulture Mediaenhanced green fluorescent proteinGreen Fluorescent ProteinsH19 long non-coding RNAIGF2 protein, mouseInsulin-Like Growth Factor IIRecombinant ProteinsRNA, Long Noncodingdistal enhancergene transcriptionIGF2muscle differentiationrecombineering

Identifiers

PMID26645089
PMCPMC4729695
OpenAlexW2195938977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.